All Reports Events Blogs Videos
Showing 44 results
  • Provider Compendium
    Nov. 28, 2025

    Everest Group’s Order-to-Cash (O2C) Products – Provider Compendium 2025 provides comprehensive and fact-based snapshots of 16 O2C products and includes insights on the global O2C products market. It examines each product’s features, enhancements, and market adoption…
  • PEAK Matrix®
    Sep. 19, 2025

    Enterprises are leveraging Employer of Record (EoR) solutions to enhance their agility, adaptability, and resilience in hiring workers globally. The shift toward remote work, combined with labor laws’ growing complexities across various regions, has accelerated the…
  • PEAK Matrix®
    Sep. 30, 2025

    Enterprises are increasingly turning to modern Order-to-Cash (O2C) products in response to growing cost pressures, tighter regulations, and the need for improved agility. Once viewed as a back-office finance function, O2C is becoming a strategic enabler…
  • State of the Market
    Sep. 22, 2025

    Process mining software analyzes process-related information from event logs generated by ERP, CRM, and other enterprise systems to offer a fact-based approach to discover, monitor, and optimize as-is processes. It is a data-based approach to process…
  • Provider Compendium
    Aug. 01, 2025

    Process mining drives operational excellence and facilitates enterprises’ digital transformation initiatives. By analyzing event logs from enterprise systems such as ERP and CRM, it offers a fact-based approach to discover, monitor, and optimize as-is processes. The…
  • PEAK Matrix®
    July 16, 2025

    In recent years, life sciences enterprises have reprioritized and overhauled their R&D investments. They now focus on streamlining their pipelines and shifting toward new and large molecules. This transformation has compelled aggressive cost containment initiatives, prompting…
  • PEAK Matrix®
    Aug. 26, 2026

    Order-to-Cash (O2C) is moving higher on the CFO agenda as enterprises seek to improve cash predictability, support evolving monetization models, and meet rising expectations for seamless stakeholder experiences. These priorities are accelerating demand for O2C products…
  • NEW
    PEAK Matrix®
    Sep. 30, 2026

    Pharmaceutical enterprises are under growing pressure to improve R&D productivity as development costs rise, scientific and therapeutic complexity increases, and timelines remain long. At the same time, advances in AI, generative AI, agentic AI, scientific computing,…
  • Technology Application Deep Dive
    April 23, 2026

    Digital Therapeutics (DTx) represent a rapidly evolving class of evidence-based interventions that leverage software as a medical device to prevent, manage, or treat medical conditions through behavioral modification, personalized feedback, and continuous data-driven support. Unlike general…
  • PEAK Matrix®
    July 31, 2025

    Life sciences enterprises are expanding their use of Veeva Vault across regulated functions, including clinical operations, regulatory information management, quality systems, promotional content management, and CRM. As adoption moves beyond single modules to integrated, cross-Vault deployments,…
  • Provider Compendium
    Sep. 30, 2025

    In recent years, life sciences enterprises have reoriented their R&D investments, prioritizing pipeline efficiency and a strategic focus on large and novel molecules. This shift has intensified efforts around cost containment and created a stronger need…
  • PEAK Matrix®
    Nov. 07, 2024

    Life sciences companies must engage customers effectively to drive business success through differentiated experiences. Hybrid commercial models require seamless, personalized interactions across channels to serve healthcare providers and patients. Advanced Customer Engagement Platforms (CEPs) go beyond…
  • PEAK Matrix®
    July 09, 2026

    Process mining software analyzes process-related information, primarily event logs from Enterprise Resource Planning (ERP) and Customer Relationship Management (CRM) systems to a fact-based approach for discovering, monitoring, and optimizing existing processes across industries and process areas.…
  • Provider Compendium
    Aug. 19, 2025

    Life sciences enterprises are reassessing how they engage with healthcare professionals and patients amid growing emphasis on hybrid commercial models and personalized experiences. This shift is prompting greater interest in next-generation Customer Engagement Platforms (CEPs) that…
  • Tech Provider Spotlight
    March 19, 2026

    Life sciences commercial engagement is undergoing a fundamental transformation as enterprises move from siloed, channel-centric models to coordinated, customer-centric omnichannel strategies. Increasing Healthcare Professionals (HCP) access constraints, evolving customer expectations, proliferation of digital channels, and mounting…
  • Provider Compendium
    Feb. 08, 2024

    Over the past year, enterprises have faced significant macroeconomic and geopolitical challenges. The potential uncertainties surrounding the implementation of the Inflation Reduction Act (IRA), the escalation in federal interest rates aimed at curbing inflation, and the…
  • PEAK Matrix®
    Sep. 28, 2023

    Over the past one year, enterprises had to overcome a series of macroeconomic and geopolitical challenges. The potential uncertainties with the implementation of the Inflation Regulation Act (IRA), and the rise in federal interest rates to…
  • Innovation Watch
    Sep. 28, 2026

    Agentic AI is becoming a significant driver for life sciences commercial organizations seeking to improve productivity, customer engagement, and decision-making across increasingly complex workflows. Commercial teams are exploring its use across product launch, pricing and market…
  • Tech Provider Spotlight
    June 02, 2026

    The digital advertising ecosystem is significantly transforming as traditional demand-side platforms evolve into omnichannel advertising platforms. What began as automated tools to buy display advertising has expanded into sophisticated platforms that support audience engagement across connected…
  • PEAK Matrix®
    Jan. 18, 2024

    As life sciences enterprises adapt to the post-pandemic market, global macroeconomic uncertainties and geopolitical disruptions are compelling biopharmaceutical and medical devices enterprises to rethink their future growth strategy. These enterprises are rationalizing and restructuring their portfolios,…

Items per page